113 related articles for article (PubMed ID: 20345552)
1. Consequences of screening in lung cancer: development and dimensionality of a questionnaire.
Brodersen J; Thorsen H; Kreiner S
Value Health; 2010 Aug; 13(5):601-12. PubMed ID: 20345552
[TBL] [Abstract][Full Text] [Related]
2. Consequences of screening in cervical cancer: development and dimensionality of a questionnaire.
Brodersen J; Siersma V; Thorsen H
BMC Psychol; 2018 Aug; 6(1):39. PubMed ID: 30097013
[TBL] [Abstract][Full Text] [Related]
3. Consequences of screening in abdominal aortic aneurysm: development and dimensionality of a questionnaire.
Brodersen J; Hansson A; Johansson M; Siersma V; Langenskiöld M; Pettersson M
J Patient Rep Outcomes; 2017; 2():37. PubMed ID: 30238082
[TBL] [Abstract][Full Text] [Related]
4. Psychosocial consequences in the Danish randomised controlled lung cancer screening trial (DLCST).
Rasmussen JF; Siersma V; Pedersen JH; Brodersen J
Lung Cancer; 2015 Jan; 87(1):65-72. PubMed ID: 25433982
[TBL] [Abstract][Full Text] [Related]
5. Consequences of screening in colorectal cancer (COS-CRC): development and dimensionality of a questionnaire.
Malmqvist J; Siersma V; Bang CW; Brodersen J
BMC Psychol; 2021 Jan; 9(1):7. PubMed ID: 33413695
[TBL] [Abstract][Full Text] [Related]
6. Validation of a condition-specific measure for women having an abnormal screening mammography.
Brodersen J; Thorsen H; Kreiner S
Value Health; 2007; 10(4):294-304. PubMed ID: 17645684
[TBL] [Abstract][Full Text] [Related]
7. Adaptation to Swedish and further development of the 'Consequences of Screening - Breast Cancer' questionnaire: a multimethod study.
Bolejko A; Wann-Hansson C; Zackrisson S; Brodersen J; Hagell P
Scand J Caring Sci; 2013 Jun; 27(2):475-86. PubMed ID: 22804720
[TBL] [Abstract][Full Text] [Related]
8. Psychometric properties of a Swedish version of the Consequences of Screening--Breast Cancer questionnaire.
Bolejko A; Brodersen J; Zackrisson S; Wann-Hansson C; Hagell P
J Adv Nurs; 2014 Oct; 70(10):2373-88. PubMed ID: 24617823
[TBL] [Abstract][Full Text] [Related]
9. Consequences of Screening in Breast Cancer (COS-BC): development of a questionnaire.
Brodersen J; Thorsen H
Scand J Prim Health Care; 2008; 26(4):251-6. PubMed ID: 19034808
[TBL] [Abstract][Full Text] [Related]
10. Validation of the psychosocial consequences of screening in lung cancer questionnaire in the international lung screen trial Australian cohort.
Bonney A; Brodersen J; Siersma V; See K; Marshall HM; Steinfort D; Irving L; Lin L; Li J; Pang S; Fogarty P; Brims F; McWilliams A; Stone E; Lam S; Fong KM; Manser R
Health Qual Life Outcomes; 2024 Jan; 22(1):10. PubMed ID: 38273370
[TBL] [Abstract][Full Text] [Related]
11. Methodological studies of orofacial aesthetics, orofacial function and oral health-related quality of life.
Larsson P
Swed Dent J Suppl; 2010; (204):11-98. PubMed ID: 20623943
[TBL] [Abstract][Full Text] [Related]
12. Psychosocial consequences of false positives in the Danish Lung Cancer CT Screening Trial: a nested matched cohort study.
Rasmussen JF; Siersma V; Malmqvist J; Brodersen J
BMJ Open; 2020 Jun; 10(6):e034682. PubMed ID: 32503869
[TBL] [Abstract][Full Text] [Related]
13. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
14. Psychosocial consequences of a three-month follow-up after receiving an abnormal lung cancer CT-screening result: A longitudinal survey.
Damhus CS; Quentin JG; Malmqvist J; Siersma V; Brodersen J
Lung Cancer; 2021 May; 155():46-52. PubMed ID: 33725548
[TBL] [Abstract][Full Text] [Related]
15. False-positive cancer screens and health-related quality of life.
McGovern PM; Gross CR; Krueger RA; Engelhard DA; Cordes JE; Church TR
Cancer Nurs; 2004; 27(5):347-52. PubMed ID: 15525861
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Vision Impairment Questionnaire: an evaluation of its measurement properties using Rasch analysis.
Lamoureux EL; Pallant JF; Pesudovs K; Hassell JB; Keeffe JE
Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4732-41. PubMed ID: 17065481
[TBL] [Abstract][Full Text] [Related]
17. Validity of self-reported smoking status among participants in a lung cancer screening trial.
Studts JL; Ghate SR; Gill JL; Studts CR; Barnes CN; LaJoie AS; Andrykowski MA; LaRocca RV
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1825-8. PubMed ID: 17035388
[TBL] [Abstract][Full Text] [Related]
18. The economic impact of false-positive cancer screens.
Lafata JE; Simpkins J; Lamerato L; Poisson L; Divine G; Johnson CC
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2126-32. PubMed ID: 15598770
[TBL] [Abstract][Full Text] [Related]
19. The initial development of the 'Cancer Caregiving Tasks, Consequences and Needs Questionnaire' (CaTCoN).
Lund L; Ross L; Groenvold M
Acta Oncol; 2012 Nov; 51(8):1009-19. PubMed ID: 22564144
[TBL] [Abstract][Full Text] [Related]
20. Classical Test Theory versus Rasch analysis for quality of life questionnaire reduction.
Prieto L; Alonso J; Lamarca R
Health Qual Life Outcomes; 2003 Jul; 1():27. PubMed ID: 12952544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
